Thu, Mar 5, 2015, 7:48 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Exelixis, Inc. Message Board

  • wilderguide wilderguide Feb 13, 2013 6:20 PM Flag

    NCT01708954: w &w/o erlotinib 2nd-3rd LOT NSCLC


    Recent (2/6/12) protocol changes to this trial make me think that perhaps the competitive/diagnostic/therapeutic landscape has forced some revisions. Changes in KRAS & EGFR recognitions have been added.
    What am I missing?

3.11+0.06(+1.97%)Mar 5 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.